20B

Biomark Diagnostics
20B

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€14.08M
EV
€15.02M
Shares Outstanding
105.09M
Beta
-0.52

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Biomark Diagnostics Inc.

gainify
20B

Biomark Diagnostics Inc.

20B

Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer. The company invests in and develops liquid biopsy metabolic panel assay for early stage diagnosis of lung cancer. It has a strategic partne...

Sector

Industry

CEO

Bux, Rashid Ahmed

Employees

IPO Date

Headquarters

3851 Shell Road, Suite 130, Richmond, British Columbia, V6X 2W2, Canada

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved